Premium
Male gonadal toxicity
Author(s) -
Meistrich Marvin L.
Publication year - 2009
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.22004
Subject(s) - azoospermia , medicine , procarbazine , melphalan , busulfan , chemotherapy , cyclophosphamide , oncology , toxicity , radiation therapy , chlorambucil , infertility , vincristine , pregnancy , genetics , biology
Cancer treatment with chemotherapy or radiotherapy causes gonadal toxicity in male patients. The endpoint of most concern for future reproductive options is the induction of prolonged azoospermia, which may or may not be reversible. The immediate effects of therapy and its reversibility are most readily observed in post‐pubertal patients, but the same antineoplastic regimens given to prepubertal males can induce permanent azoospermia. The probability of permanent azoospermia is related to the specific agents used and their doses. The most damaging are alkylating agents (particularly chlorambucil, procarbazine, cyclophosphamide, melphalan, and busulfan), cisplatin and radiation to the region of the testicles. Pediatr Blood Cancer 2009;53:261–266. © 2009 Wiley‐Liss, Inc.